Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

5-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole

EU orphan designation number: EU/3/08/591   
Active ingredient: 5-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: Summit (Oxford) Limited
85b Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/12/2008 Centralised Orphan - Designation EMEA/OD/065/08 (2008)8166 of 04/12/2008
26/05/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/065/08/T/01 (2009)4112 of 20/05/2009
11/03/2011 Centralised Orphan - Transfer of orphan designation EMEA/OD/065/08/T/02 (2011)1686 of 09/03/2011
28/01/2014 Centralised Orphan - Change of address